BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32856611)

  • 1. Circulating Insulin-Like Growth Factor-1 and Risk of Total and 19 Site-Specific Cancers: Cohort Study Analyses from the UK Biobank.
    Qian F; Huo D
    Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2332-2342. PubMed ID: 32856611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Insulin-like Growth Factor-I Concentrations and Risk of 30 Cancers: Prospective Analyses in UK Biobank.
    Knuppel A; Fensom GK; Watts EL; Gunter MJ; Murphy N; Papier K; Perez-Cornago A; Schmidt JA; Smith Byrne K; Travis RC; Key TJ
    Cancer Res; 2020 Sep; 80(18):4014-4021. PubMed ID: 32709735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank.
    Watts EL; Fensom GK; Smith Byrne K; Perez-Cornago A; Allen NE; Knuppel A; Gunter MJ; Holmes MV; Martin RM; Murphy N; Tsilidis KK; Yeap BB; Key TJ; Travis RC
    Int J Cancer; 2021 May; 148(9):2274-2288. PubMed ID: 33252839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating insulin-like growth factor-I and risk of 25 common conditions: outcome-wide analyses in the UK Biobank study.
    Papier K; Knuppel A; Perez-Cornago A; Watts EL; Tong TYN; Schmidt JA; Allen N; Key TJ; Travis RC
    Eur J Epidemiol; 2022 Jan; 37(1):25-34. PubMed ID: 34746972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective analyses of testosterone and sex hormone-binding globulin with the risk of 19 types of cancer in men and postmenopausal women in UK Biobank.
    Watts EL; Perez-Cornago A; Knuppel A; Tsilidis KK; Key TJ; Travis RC
    Int J Cancer; 2021 Aug; 149(3):573-584. PubMed ID: 33720423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ∼430 000 women.
    Murphy N; Knuppel A; Papadimitriou N; Martin RM; Tsilidis KK; Smith-Byrne K; Fensom G; Perez-Cornago A; Travis RC; Key TJ; Gunter MJ
    Ann Oncol; 2020 May; 31(5):641-649. PubMed ID: 32169310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of circulating insulin-like growth factor-I with intake of dietary proteins and other macronutrients.
    Watling CZ; Kelly RK; Tong TYN; Piernas C; Watts EL; Tin Tin S; Knuppel A; Schmidt JA; Travis RC; Key TJ; Perez-Cornago A
    Clin Nutr; 2021 Jul; 40(7):4685-4693. PubMed ID: 34237695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor I and risk of incident cancer in elderly men - results from MrOS (Osteoporotic Fractures in Men) in Sweden.
    Carlzon D; Svensson J; Petzold M; Karlsson MK; Ljunggren Ö; Haghsheno MA; Damber JE; Mellström D; Ohlsson C
    Clin Endocrinol (Oxf); 2016 May; 84(5):764-70. PubMed ID: 26440042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-1 and site-specific cancers: A Mendelian randomization study.
    Larsson SC; Carter P; Vithayathil M; Kar S; Mason AM; Burgess S
    Cancer Med; 2020 Sep; 9(18):6836-6842. PubMed ID: 32717139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum insulin-like growth factors and mortality in localised and advanced clinically detected prostate cancer.
    Rowlands MA; Holly JM; Hamdy F; Phillips J; Goodwin L; Marsden G; Gunnell D; Donovan J; Neal DE; Martin RM
    Cancer Causes Control; 2012 Feb; 23(2):347-54. PubMed ID: 22183619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between food group intakes and circulating insulin-like growth factor-I in the UK Biobank: a cross-sectional analysis.
    Watling CZ; Kelly RK; Tong TYN; Piernas C; Watts EL; Tin Tin S; Knuppel A; Schmidt JA; Travis RC; Key TJ; Perez-Cornago A
    Eur J Nutr; 2023 Feb; 62(1):115-124. PubMed ID: 35906357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of platelets with obesity in relation to lung cancer risk in the UK Biobank cohort.
    Christakoudi S; Tsilidis KK; Evangelou E; Riboli E
    Respir Res; 2023 Oct; 24(1):249. PubMed ID: 37848891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Body Shape Index (ABSI), hip index, and risk of cancer in the UK Biobank cohort.
    Christakoudi S; Tsilidis KK; Evangelou E; Riboli E
    Cancer Med; 2021 Aug; 10(16):5614-5628. PubMed ID: 34196490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank.
    Tin Tin S; Reeves GK; Key TJ
    Br J Cancer; 2021 Jul; 125(1):126-134. PubMed ID: 33864017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating insulin-like growth factor I in relation to melanoma risk in the European prospective investigation into cancer and nutrition.
    Bradbury KE; Appleby PN; Tipper SJ; Travis RC; Allen NE; Kvaskoff M; Overvad K; Tjønneland A; Halkjaer J; Cervenka I; Mahamat-Saleh Y; Bonnet F; Kaaks R; Fortner RT; Boeing H; Trichopoulou A; La Vecchia C; Stratigos AJ; Palli D; Grioni S; Matullo G; Panico S; Tumino R; Peeters PH; Bueno-de-Mesquita HB; Ghiasvand R; Veierød MB; Weiderpass E; Bonet C; Molina E; Huerta JM; Larrañaga N; Barricarte A; Merino S; Isaksson K; Stocks T; Ljuslinder I; Hemmingsson O; Wareham N; Khaw KT; Gunter MJ; Rinaldi S; Tsilidis KK; Aune D; Riboli E; Key TJ
    Int J Cancer; 2019 Mar; 144(5):957-966. PubMed ID: 30191956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical activity, dietary protein and insulin-like growth factor 1: Cross-sectional analysis utilising UK Biobank.
    Gulick CN; Peddie MC; Cameron C; Bradbury K; Rehrer NJ
    Growth Horm IGF Res; 2020 Dec; 55():101353. PubMed ID: 33002777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does insulin-like growth factor moderate the association between height and risk of cancer at 24 sites?
    Parra-Soto S; Ho FK; Pell JP; Celis-Morales C
    Br J Cancer; 2020 Nov; 123(11):1697-1704. PubMed ID: 32921791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-Like Growth Factor 1 and Risk of Cardiovascular Disease: Results From the UK Biobank Cohort Study.
    Lin J; Yang L; Huang J; Liu Y; Lei X; Chen R; Xu B; Huang C; Dou W; Wei X; Liu D; Zhang P; Huang Y; Ma Z; Zhang H
    J Clin Endocrinol Metab; 2023 Aug; 108(9):e850-e860. PubMed ID: 36810801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of inflammatory biomarkers and growth factors and risk of glioma in the UK Biobank.
    Cote DJ; Creed JH; Samanic CM; Gerke TA; Stampfer MJ; Smith-Warner SA; Egan KM
    Cancer Epidemiol; 2021 Dec; 75():102043. PubMed ID: 34564026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.